Strategic partnership between Mission Bio and Fulgent Genetics (FLGT) will enable drug developers to leverage single-cell multi-omics for biomarker discovery, clinical research, and single-cell MRD ...

Looking to expand its legacy in metabolic conditions, Novo Nordisk has inked a multiyear research pact with Variant Bio to better understand the genetics underlying disease across diverse populations.

SAN DIEGO--(BUSINESS WIRE)-- Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) (“Ligand,” the “Company” or “we”) announced that it has entered into a merger agreement, pursuant to which its ...